🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This study will be an open label, exploratory immunogenicity study conducte...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Start Date
2015-04
Trial ID
NCT02398396
Treatments Being Tested
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
The aim of this study is to determine the immunologic noninferiority of Men...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC, Birmington Pediatric Assocaites
Start Date
2020-06-17
Trial ID
NCT04440163
Treatments Being Tested
The goal of this clinical trial is to evaluate the humoral immunogenicity o...
Status
Recruiting
Location
Rheumatology Division, Faculdade de Medicina da USP
Start Date
2026-02-19
Trial ID
NCT07252804
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
This study compares the safety and immunogenicity profile of combined hepat...
Status
Completed
Location
03, Novartis Investigational Site
Start Date
2011-10
Trial ID
NCT01453348
The research objective is to evaluate the safety and tolerability of the re...
Status
Unknown
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2023-07-22
Trial ID
NCT06314880